TrialBone marrow transplantation2013

Intermediate-dose Ara-C plus G-CSF for stem cell mobilization in patients with lymphoid malignancies, including predicted poor mobilizers.

S Giebel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.